CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −15,114 | $92.81 | $1.4M | 33,013 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −8,430 | $93.97 | $792K | 24,583 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −6,282 | $94.92 | $596K | 18,301 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −3,672 | $96.03 | $353K | 14,629 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,760 | $97.10 | $171K | 12,869 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,575 | $97.76 | $252K | 10,294 |
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −16,111 | 7,250 | ||
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −21,059 | 0 | ||
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −3,760 | 23,492 | ||
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −1,658 | 0 | ||
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −16,112 | 11,277 | ||
| 2026-10-30 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −10,895 | 25,205 | ||
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +38,545 | $30.93 | $1.2M | 108,467 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +39,042 | $17.92 | $700K | 147,509 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −41,789 | $92.02 | $3.8M | 105,720 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −16,056 | $92.85 | $1.5M | 89,664 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,841 | $93.91 | $642K | 82,823 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −4,821 | $94.86 | $457K | 78,002 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −4,000 | $95.97 | $384K | 74,002 |
| 2026-10-30 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,925 | $97.06 | $187K | 72,077 |
Page 4 of 74 · 1,467 trades